Agastiya Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Agastiya Biotech's estimated annual revenue is currently $1.1M per year.
- Agastiya Biotech's estimated revenue per employee is $155,000
Employee Data
- Agastiya Biotech has 7 Employees.
- Agastiya Biotech grew their employee count by -22% last year.
Agastiya Biotech's People
Name | Title | Email/Phone |
---|---|---|
1 | Director | Reveal Email/Phone |
2 | Global Partnerships | Reveal Email/Phone |
Agastiya Biotech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Agastiya Biotech?
Agastiya Biotech merges advanced, Eastern knowledge with rigorous Western R&D in order to deliver breakthrough innovative pharmaceuticals to the marketplace. Over 40% of all pharmaceutical drugs, including sophisticated chemotherapy and anti-viral drugs, are derived from natural plant sources. Through investigation of ancient Eastern botanical knowledge combined with high throughput and AI driven analysis, Agastiya Biotech engineers best in class novel small molecules for treatment of disease. We are leading the discovery and design of ground-breaking small molecules to revolutionize medicine and find a cure for the diseases of our time.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
-22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 7 | 0% | N/A |
#2 | $0.5M | 7 | -12% | N/A |
#3 | $0.5M | 7 | -42% | N/A |
#4 | $0.6M | 8 | N/A | N/A |
#5 | $2.8M | 11 | 0% | N/A |